Pfizer, India talk expedited COVID-19 vaccine approval to combat shortage

Pfizer’s CEO Albert Bourla announced Monday the company is in talks with the Indian government to fast track the approval process for its COVID-19 vaccine to address the country’s devastating coronavirus crisis and vaccine scarcities.

“Pfizer is aware that access to vaccines is critical to ending this pandemic,” Bourla said in a statement posted to LinkedIn Monday. “Unfortunately, our vaccine is not registered in India although our application was submitted months ago. We are currently…

Click here to view the original article.

Show More

Related Articles

Back to top button